Skip to Main Content

Paper Details

Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.
Blood Adv
23
2022
ALL, B, B-, B-ALL, B-cell acute lymphoblastic leukemia, CAR T-cell, CAR T-cell products, CD19, CD19-CAR T-cell, CD19-CAR T-cell product, CD19-CARs, CD19-specific chimeric antigen receptors, CD4+, CD4+ CAR T cells, CD8, CD8+, CD8+ CAR T cells, CD8+ CD19-CAR T cells, Patients, T cells, cytokine, cytokine release syndrome, morphologic blasts, neurotoxicity, participants, patients, relapsed and/or refractory, relapsed/refractory
Author NameAffiliation
Yongjin LiSt. Jude Children's Research Hospital
Yongjin LiSt. Jude Children's Research Hospital
Paul G ThomasSt. Jude Children's Research Hospital
Ching-Hon PuiSt. Jude Children's Research Hospital
  • 1 - 4

Datasets

Release 1.2